Enhance Biopharmaceutical Drug Discovery with Core Informatics Biologics Applications
CIOREVIEW >> Pharma & life sciences >>

Enhance Biopharmaceutical Drug Discovery with Core Informatics Biologics Applications

By CIOReview | Wednesday, March 9, 2016

BRANFORD, CT- In the recent years the biopharmaceutical companies have experienced a strong demand for comprehensive informatics solution for better therapeutic biologics discovery. To drive the innovation for therapeutic biologics discovery and development, scientific data management software provider, Core Informatics has released a suite of new applications. The apps provide capabilities for scientists and researchers to seamlessly execute biologic sample registration and HTS workflows. The combination of biologics registration, biochemical and cell-based HTS, and sample inventory applications, provides traceability across drug discovery workflows.

"These new apps provide biopharma organizations the required ability to define, collect, and securely share diverse data within a single platform for efficient biologics data management,” Anthony Uzzo, President and Co-Founder of Core Informatics. The apps include configurable dashboards to provide lab teams and business leaders with immediate visibility into project status and key metrics to enhance decision making. Customers are able to add new sample types and relationships, and container types, through configuration that makes new data structure available to scientists in the lab without any custom code. The apps further can be used individually to support a portion of a larger biologics workflow, or linked together to provide an enterprise-level platform to support all of an organization's biologics activities.

The new apps are built on Core Informatics' Platform for Science (PFS), enabling customers to add on to their existing PFS deployment over time. These apps can be utilized through Core Informatics' Platform for Science Marketplace. "We use Core's platform to support our structural and functional biology efforts as part of our Integrated Lead Discovery Platform," said Art Morales, Vice President, Technology and Corporate Development at Beryllium. "We are excited about the expansion of the biologics apps suite in Core's Platform for Science Marketplace, continuing their commitment to provide innovative informatics solutions for drug discovery."

Check This Out: Top Drug Discovery Companies